Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice

The PD-1–PD-L1 pathway inhibits perforin-mediated killing of PD-L1+ vascular endothelial cells by CD8+ T cells, thereby limiting vascular damage during systemic LCMV infection.

[1]  C. Drake,et al.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[2]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[3]  Y. Najjar,et al.  Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanisms , 2011, European journal of immunology.

[4]  Yuzhang Wu,et al.  Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection , 2011, PLoS pathogens.

[5]  Arthur S Slutsky,et al.  Broken Barriers: A New Take on Sepsis Pathogenesis , 2011, Science Translational Medicine.

[6]  R. Bhadra,et al.  Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1–PDL-1 blockade , 2011, Proceedings of the National Academy of Sciences.

[7]  Mark A. Smith,et al.  Pathogenesis of lassa fever in cynomolgus macaques , 2011, Virology Journal.

[8]  M. Matthay,et al.  The acute respiratory distress syndrome: pathogenesis and treatment. , 2011, Annual review of pathology.

[9]  A. Sher,et al.  CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition , 2011, The Journal of Immunology.

[10]  S. Johnston,et al.  RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. , 2011, The Journal of infectious diseases.

[11]  T. Gajewski,et al.  Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer. , 2010, Current opinion in investigational drugs.

[12]  F. Chiodi.  New therapy to revert dysfunctional antibody responses during HIV-1 infection. , 2010, The Journal of clinical investigation.

[13]  D. Hinton,et al.  Enhanced Antiviral T Cell Function in the Absence of B7-H1 Is Insufficient To Prevent Persistence but Exacerbates Axonal Bystander Damage during Viral Encephalomyelitis , 2010, The Journal of Immunology.

[14]  Lieping Chen,et al.  B7‐H1 expression on non‐B and non‐T cells promotes distinct effects on T‐ and B‐cell responses in autoimmune arthritis , 2010, European journal of immunology.

[15]  R. Ahmed,et al.  Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation , 2010, The Journal of experimental medicine.

[16]  M. Maio,et al.  The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications. , 2010, Seminars in oncology.

[17]  D. Brooks,et al.  Translating insights from persistent LCMV infection into anti-HIV immunity , 2010, Immunologic research.

[18]  S. Almo,et al.  Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis , 2010, Proceedings of the National Academy of Sciences.

[19]  Scott N. Mueller,et al.  PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. , 2010, The Journal of clinical investigation.

[20]  Israel Lowy,et al.  Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Loise M. Francisco,et al.  The PD‐1 pathway in tolerance and autoimmunity , 2010, Immunological reviews.

[22]  G. Freeman,et al.  Role of PD-1 in regulating acute infections. , 2010, Current opinion in immunology.

[23]  D. Engeler,et al.  IFN‐γ‐receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T‐cell‐mediated injury of vascular endothelial cells , 2010, European journal of immunology.

[24]  S. Günther,et al.  T Cell-Dependence of Lassa Fever Pathogenesis , 2010, PLoS pathogens.

[25]  S. Targan,et al.  Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. , 2010, Cancer immunity.

[26]  Antonio Polley,et al.  Tissue-Specific Differences in PD-1 and PD-L1 Expression during Chronic Viral Infection: Implications for CD8 T-Cell Exhaustion , 2009, Journal of Virology.

[27]  A. Srikiatkhachorn.  Plasma leakage in dengue haemorrhagic fever , 2009, Thrombosis and Haemostasis.

[28]  E. Wherry,et al.  Redefining Chronic Viral Infection , 2009, Cell.

[29]  P. Katsikis,et al.  Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion1 , 2009, The Journal of Immunology.

[30]  Scott N. Mueller,et al.  High antigen levels are the cause of T cell exhaustion during chronic viral infection , 2009, Proceedings of the National Academy of Sciences.

[31]  T. Gajewski,et al.  Costimulatory and coinhibitory receptors in anti‐tumor immunity , 2009, Immunological reviews.

[32]  G. Freeman,et al.  Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade , 2009, PLoS pathogens.

[33]  G. Freeman,et al.  Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade , 2008, Nature.

[34]  Michael L. Dustin,et al.  MYELOMONOCYTIC CELL RECRUITMENT CAUSES FATAL CNS VASCULAR INJURY DURING ACUTE VIRAL MENINGITIS , 2008, Nature.

[35]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[36]  G. Freeman,et al.  Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade , 2008, Proceedings of the National Academy of Sciences.

[37]  Lieping Chen,et al.  Detrimental Contribution of the Immuno-Inhibitor B7-H1 to Rabies Virus Encephalitis1 , 2008, The Journal of Immunology.

[38]  G. Pedrazzi,et al.  Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. , 2008, Journal of hepatology.

[39]  Scott N. Mueller,et al.  Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection , 2008, The Journal of experimental medicine.

[40]  G. Freeman,et al.  Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8+ T-Cell–Mediated Injury in the Heart , 2007, Circulation.

[41]  E. Harris,et al.  Murine Model for Dengue Virus-Induced Lethal Disease with IncreasedVascular Permeability , 2006, Journal of Virology.

[42]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[43]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[44]  S. Kunz,et al.  Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor α-Dystroglycan , 2005, Journal of Virology.

[45]  A. Sharpe,et al.  The B7/CD28 costimulatory family in autoimmunity , 2005, Immunological reviews.

[46]  G. Freeman,et al.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Zhu,et al.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. , 2004, Immunity.

[48]  G. Freeman,et al.  Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.

[49]  T. Okazaki,et al.  PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver , 2003, The Journal of experimental medicine.

[50]  G. Freeman,et al.  Expression and Regulation of the PD‐L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells , 2002, Microcirculation.

[51]  K. Campbell,et al.  Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan , 2001, The Journal of cell biology.

[52]  T. Honjo,et al.  PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. , 2001, Trends in immunology.

[53]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[54]  F. Chisari,et al.  Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice , 2000, The Journal of experimental medicine.

[55]  I. Lukashevich,et al.  Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL‐8 and TNF‐α gene expression , 1999, Journal of medical virology.

[56]  T. Honjo,et al.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.

[57]  T. Honjo,et al.  Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. , 1998, International immunology.

[58]  Lisa R Leon,et al.  Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[59]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[60]  F. Lemonnier,et al.  HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice , 1997, The Journal of experimental medicine.

[61]  I. Campbell.  Exacerbation of lymphocytic choriomeningitis in mice treated with the inducible nitric oxide synthase inhibitor aminoguanidine , 1996, Journal of Neuroimmunology.

[62]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[63]  C. Chiang,et al.  Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. , 1994, Journal of immunology.

[64]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[65]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[66]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[67]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[68]  J. McCormick,et al.  Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. , 1987, The Journal of infectious diseases.

[69]  A. Imbriano.  [Blood coagulation]. , 1955, La Semana medica.